Belite Bio, Inc (BLTE) Tops Q4 EPS by 5c

Belite Bio, Inc (NASDAQ: BLTE) reported Q4 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Belite Bio, Inc (BLTE) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene
• Beam Global reports Q2 2026 revenue above $8.5M, up 170% from Q1